ucltb.bsky.social
UCL-TB
@ucltb.bsky.social
520 followers 52 following 15 posts
UCL-TB is a broad and cross-disciplinary tuberculosis research network that spans University College London and our partners throughout the world. We're also on X (@UCLTB). Website: https://www.ucl.ac.uk/tb/ YouTube: https://www.youtube.com/channel/UCUc
www.ucl.ac.uk
Posts Media Videos Starter Packs
ucltb.bsky.social
UCL-TB @ucltb.bsky.social · Apr 14
Watch the video of our recent World TB Day Symposium 2025. Details at www.ucl.ac.uk/tb/events/wo... @tb-lshtm.bsky.social
2
Reposted by UCL-TB
tb-lshtm.bsky.social
TB Centre LSHTM @tb-lshtm.bsky.social · Apr 9
Did you miss @tb-lshtm.bsky.social & @ucltb.bsky.social Symposium? Or would you like to watch again? Good news: the full recording is now available! tinyurl.com/bdh8fymx
@sedonasweeney.bsky.social @kchorton.bsky.social @reinhouben.bsky.social
4 3
ucltb.bsky.social
UCL-TB @ucltb.bsky.social · Apr 1
Last month we held a webinar on 'TB in the UK'. 500 people turned out to join the discussion. Read some of what we heard in this week's BMJ editorial piece www.bmj.com/content/388/.... #tuberculosis
Tuberculosis in the UK
Multipronged action is needed to reverse rising rates Tuberculosis (TB) is the world’s oldest pandemic, accounting for around a billion deaths in the past two centuries.1 In the UK, after more than a...
www.bmj.com
1 4
ucltb.bsky.social
UCL-TB @ucltb.bsky.social · Mar 24
Out today: The need to scale up community-wide screening for TB irrespective of symptoms, if we are serious about ending TB. ijidonline.com/article/S120... @mrcctu.bsky.social
Scaling-up symptom-agnostic, community-wide screening towards global tuberculosis elimination: opportunities, challenges and lessons from history
Globally in 2023, 8.2 million people with a new episode of tuberculosis (TB) were diagnosed and notified.[1] This is the highest number of TB notifications for a single year since the World Health Org...
ijidonline.com
2 4
ucltb.bsky.social
UCL-TB @ucltb.bsky.social · Mar 24
Today: Online link for World TB Day symposium 9-5 GMT: lshtm.zoom.us/j/92519123639. Programme information at ucl.ac.uk/tb/events/wo...
3 3
ucltb.bsky.social
UCL-TB @ucltb.bsky.social · Mar 17
1 week today until our World TB Day Symposium! Join us in-person (more tickets available) or online.
kchorton.bsky.social
Katherine Horton @kchorton.bsky.social · Mar 5
Register now to join us for this year's #WTBD symposium!

With sessions on post-TB lung disease, the UK's place in national and international policy, and asymptomatic TB, plus a debate on Pan-TB regimens and turbo talks from early career researchers @tb-lshtm.bsky.social & @ucltb.bsky.social!
2 5
ucltb.bsky.social
UCL-TB @ucltb.bsky.social · Mar 4
Video now online for 'TB in the UK' webinar youtube.com/watch?v=h5Lp... #tuberculosis
1 4
Reposted by UCL-TB
btnin24.bsky.social
btnin24.bsky.social @btnin24.bsky.social · Feb 18
Excellent work by @msf.ca @msfsci.bsky.social, @who.int, Uzbekistan and Belarusian colleagues on real world evidence for #BPaLM and #BPaLC 6 months treatment for rifampicin-resistant #TB @lshtmamrcentre.bsky.social @ucltb.bsky.social
The Effectiveness and Safety of Bedaquiline, Pretomanid, and Linezolid (BPaL)–Based Regimens for Rifampicin-Resistant Tuberculosis in Non-Trial Settings—A Prospective Cohort Study in Belarus and Uzbek...
Treatment for multidrug-resistant/rifampicin-resistant tuberculosis (TB) and pre–extensively drug-resistant TB using 24-week all-oral bedaquiline, pretoman
academic.oup.com
1 1
ucltb.bsky.social
UCL-TB @ucltb.bsky.social · Feb 10
Person-Centred Care for TB-affected Households symposium
- Tomorrow 11th Feb, 1230-1400 GMT
- Hybrid, no registration required
www.ucl.ac.uk/tb/person-ce...
2 2
ucltb.bsky.social
UCL-TB @ucltb.bsky.social · Jan 28
Join our "Person-Centred Care for TB-affected Households" hybrid symposium www.ucl.ac.uk/tb/person-ce... #tuberculosis
- Tues 11 Feb 2025, 1230-1400 GMT
- No pre-registration needed
3 3
ucltb.bsky.social
UCL-TB @ucltb.bsky.social · Jan 28
Why is TB incidence in the UK on the rise? Join our free webinar on 'TB in the UK' to hear major stakeholders discuss why this is happening, and how we can best respond. Thurs 6th Feb, 3-5pm www.ucl.ac.uk/tb/tb-uk-web...
1 2
ucltb.bsky.social
UCL-TB @ucltb.bsky.social · Jan 21
"Person-Centred Care for TB-affected Households": hybrid symposium
11 Feb 2025, 1230-1400 GMT no pre-registration
www.ucl.ac.uk/tb/person-ce... #tuberculosis
6 9
ucltb.bsky.social
UCL-TB @ucltb.bsky.social · Jan 14
After falling for 10 years, TB incidence in the UK is on the rise. Join our free webinar on 'TB in the UK' to discuss why this is happening, and how we can best respond. Thurs 6th Feb, 3-5pm www.ucl.ac.uk/tb/tb-uk-web...
1 6
ucltb.bsky.social
UCL-TB @ucltb.bsky.social · Jan 10
After falling for 10 years, TB incidence in the UK is on the rise. Join our free webinar on 'TB in the UK' to discuss why this is happening, and how we can best respond. Thurs 6th Feb, 3-5pm www.ucl.ac.uk/tb/tb-uk-web...
3
ucltb.bsky.social
UCL-TB @ucltb.bsky.social · Jan 9
In-person London seminar on TB comorbidities by Prof Jonathan Golub next Wed 15th January at 1730 GMT www.ucl.ac.uk/tb/seminar-t... #tuberculosis
5
ucltb.bsky.social
UCL-TB @ucltb.bsky.social · Jan 8
In-person London seminar on TB comorbidities by Prof Jonathan Golub next Wed 15th January at 1730 GMT hosted by Prof Lele Rangaka www.ucl.ac.uk/tb/seminar-t... #tuberculosis
2 5
Reposted by UCL-TB
gpollara.bsky.social
Gabriele Pollara @gpollara.bsky.social · Aug 2
Bedaquiline has been a great development in the treatment of drug-resistant TB. But it's future is uncertain due to rising resistance levels. Great review here.... #IDSky #Microsky #Infectiousdiseases #TB #Tuberculosis
www.sciencedirect.com/science/arti...
Bedaquiline: what might the future hold?
Tuberculosis drug development has stagnated for decades, so the recent availability of bedaquiline is welcome. Bedaquiline-containing regimens, now th…
www.sciencedirect.com
11 19
Reposted by UCL-TB
emilybethwong.bsky.social
Emily Wong @emilybethwong.bsky.social · Dec 5
Thanks for this beautiful 🧵!
Wonderful to work with @gpollara.bsky.social
@helgardclaassen.bsky.social and @maphemthembu.bsky.social on this. Appreciate the support from @niaidnews.bsky.social @ahri-news.bsky.social and @ucltb.bsky.social. 3rd and final PhD paper for Maphe! 🎉 💫
gpollara.bsky.social
Gabriele Pollara @gpollara.bsky.social · Dec 5
Really pleased to share collaborative project led by @emilybethwong.bsky.social & 1st author
@maphemthembu.bsky.social

A careful dissection of dysfunctional immune responses in ART-naive HIV infection. TL:DR bronchoalveolar ≠ blood responses
#HIVSky #IDSky #ImmunoSky

www.cell.com/iscience/ful...
Dysfunctional bronchoalveolar effector memory CD8+ T cells in tuberculosis-exposed people living with antiretroviral-naïve HIV infection
Immunology; Virology
www.cell.com
1 4 8
Reposted by UCL-TB
mrcctu.bsky.social
MRC Clinical Trials Unit at UCL @mrcctu.bsky.social · Nov 13
Today at the #UnionConf2024, Trinh Duong discussed safety of and adherence to levofloxacin to prevent multidrug-resistant #tuberculosis in the TB-CHAMP & VQUIN trials.

Get the full story behind these #TB trials on our podcast. Listen now👇
https://buff.ly/4euqqTG
#MedSky #IDSky @ucltb.bsky.social
TB-CHAMP, VQUIN, and the first effective treatment to prevent multidrug-resistant tuberculosis
In September 2024, the World Health Organization (WHO) released new guidance on preventative treatment for tuberculosis (TB). Thanks to new evidence from two randomised controlled clinical trials, the
buff.ly
1 4
ucltb.bsky.social
UCL-TB @ucltb.bsky.social · Nov 12
DR-TPT webinar video now available. The edited recording of our webinar event on 'Preventive therapy for drug-resistant tuberculosis' can be seen here: youtube.com/watch?v=iyPx... @mrcctu.bsky.social
2 2 7